|
OTUD4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.090300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.001400E-01 |
| Normal-vs-Stage2 |
5.646200E-01 |
| Normal-vs-Stage3 |
1.135500E-02 |
| Normal-vs-Stage4 |
1.764260E-02 |
| Stage1-vs-Stage2 |
9.565400E-01 |
| Stage1-vs-Stage3 |
4.201500E-02 |
| Stage1-vs-Stage4 |
9.366300E-02 |
| Stage2-vs-Stage3 |
2.194600E-01 |
| Stage2-vs-Stage4 |
2.597000E-01 |
| Stage3-vs-Stage4 |
9.143600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.031380E-01 |
| Normal-vs-AfricanAmerican |
1.921140E-03 |
| Normal-vs-Asian |
5.940000E-01 |
| Caucasian-vs-AfricanAmerican |
4.113700E-02 |
| Caucasian-vs-Asian |
3.407400E-01 |
| AfricanAmerican-vs-Asian |
4.872500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.088100E-02 |
| Normal-vs-Female |
2.545600E-01 |
| Male-vs-Female |
3.767400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.032100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.650400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.140000E-02 |
| Normal-vs-Age(81-100Yrs) |
9.788300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.210600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.693200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.826200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.438400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.615800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.105400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.064600E-01 |
| Normal-vs-Grade 2 |
7.646000E-01 |
| Normal-vs-Grade 3 |
4.203700E-03 |
| Normal-vs-Grade 4 |
3.638700E-03 |
| Grade 1-vs-Grade 2 |
6.826200E-01 |
| Grade 1-vs-Grade 3 |
6.739800E-02 |
| Grade 1-vs-Grade 4 |
4.534000E-02 |
| Grade 2-vs-Grade 3 |
2.643800E-03 |
| Grade 2-vs-Grade 4 |
3.120400E-03 |
| Grade 3-vs-Grade 4 |
4.753400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.827000E-01 |
| Normal-vs-ccB subtype |
6.477800E-02 |
| ccA subtype-vs-ccB subtype |
1.493620E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.192800E-01 |
| Normal-vs-N1 |
5.878800E-01 |
| N0-vs-N1 |
9.393600E-01 |
|
|
